Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 220 clinical trials
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists …

MRI
interferon
cns involvement
autologous stem cell infusion
gliomas
  • 1032 views
  • 17 Jun, 2022
  • 105 locations
Tamoxifen for Well Differentiated Neurodendocrine Tumors and Hormone Receptor Positive Expression

/or progesterone) expression by immunohistochemistry (IHC).

pancreatic net
measurable disease
neutrophil count
who 2017
platelet count
  • 0 views
  • 05 May, 2022
  • 1 location
PD-L1 Expression in Lung Cancer (PELICAN)

immunohistochemistry (IHC).

lung carcinoma
  • 0 views
  • 09 Jun, 2022
  • 1 location
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

immunohistochemistry assay and examine the relationship with response to therapy. Perform pharmacogenomics analyses of drug metabolism and transport proteins through germline DNA examination.

dopamine
measurable disease
amylase
metastatic disease
experimental therapy
  • 1 views
  • 07 Feb, 2022
  • 1 location
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

subjects must have intact Rb, identified at the time of screening, by immunohistochemistry testing of submitted tumor specimen. Subjects will receive Abemaciclib 200 mg twice daily until progression or

systemic therapy
measurable disease
metastasis
neutrophil count
immunomodulators
  • 11 views
  • 23 Apr, 2022
  • 4 locations
Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions

, possibility to perform immunohistochemistry and the adverse event rate.

  • 0 views
  • 12 May, 2021
  • 1 location
HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody

radionuclide therapy in Breast Cancer. The SPECT/CT results will compare with the existing gold standard " HER2 expression detection" by biopsy tissue immunohistochemistry (IHC) and/or Fluorescence in Situ

  • 0 views
  • 28 Jan, 2021
  • 1 location
Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation

provides poor therapeutic effect, leading to tumor progression or intolerance. Before immunotherapy, the PD-L1 expression was confirmed negative in the graft liver by immunohistochemistry, and patients

immunohistochemistry
sorafenib
metastases
immune globulin
metastasis
  • 0 views
  • 15 May, 2022
  • 1 location
Sentinel Lymph Node Mapping and Analysis in Colon Cancer Using Indocyanine Green Dye

nodes which are most likely to harbour metastasis. These sentinel lymph nodes can be subsequently subjected to detailed pathologic examination and immunohistochemistry which increases the likelihood of

colectomy
indocyanine green
metastasis
  • 0 views
  • 25 Mar, 2022
  • 1 location
FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.

-Embedded (FFPE) samples from the tumour resection specimen and will consist of histological characterization, immuno assays, multiplex immunohistochemistry, DNA sequencing and single nuclei RNA sequencing

  • 0 views
  • 26 Jan, 2021
  • 1 location